• Preference For Cervical Cancer Screening In Rural China- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Economic Evaluation of Drug Wastage Impact on Healthcare Expenditures in French Hospitals

    Nov 1, 2016, 00:00

  • Evaluating Therapeutic Treatments for Psoriatic Arthritis- Can We Make Better use of Patient Data Registries?

    Nov 1, 2016, 00:00

  • Real-World Health Outcomes, Economic Impacts, and Cost-Effectiveeness of a Beijing Municipal Government Funded Free-Drug Rpogram in Community Schizophrenia Patients in Beijing, China

    Nov 1, 2016, 00:00

  • Pain Management of Lung Cancer Patient in Hungary

    Nov 1, 2016, 00:00

  • Assessing The Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Inoperable Patients with Severe Aortic Stenosis in UK

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Neoadjuvant Pertuzumab and Trastuzumab in Patients with Locally Advanced, Inflammatory, or Early HER-2 Positive Breast Cancer

    Nov 1, 2016, 00:00

  • Utilisation and Dosage Patterns of Intravenous Echinocandins for Treatment of Invasive Fungal Infections Within Hospitals in England

    Nov 1, 2016, 00:00

  • The Impact of Dementia on the Outcomes of Treatments For Acute Coronary Syndrome

    Nov 1, 2016, 00:00

  • Cost of Illness of Ankylosing Spondylitis In Egypt From Payer Prospective

    Nov 1, 2016, 00:00

  • Benefit Assessment of Medical Devices of High Risk Classes in Germany- Adaptive Approaches to Balance Early Access and Safety and Efficacy Required?

    Nov 1, 2016, 00:00

  • Assessment of Carotid Stenting Safety- A French Exhaustive Cohort Study Based on The Re-Use of Routine National Health Database

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sunitinib Versus Best Supportive Care for The Treatment of Metastatic Renal Cell Carcinoma in Chile

    Nov 1, 2016, 00:00

  • Diareg – Results from an Diabetes Register with Focus on Patient Reported Outcomes

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in the UK

    Nov 1, 2016, 00:00

  • The Cost of Cognitive Impairment in Patient with Major Depressive Disorder

    Nov 1, 2016, 00:00

  • Retrospective Database Analysis of Hospital Length of Stay, Discharge Location, And Readmissions Among Patients Undergoing Total Knee Arthroplasty (TKA) In The United States

    Nov 1, 2016, 00:00

  • Therapeutic Indication of Lyophilized Hydrocortisone to the Treatment of Trichinosis with Neurological and / or Myocardial Involvement

    Nov 1, 2016, 00:00

  • Exploring The Impact of Adding A Respiratory Dimension to The EQ-5D-5L

    Nov 1, 2016, 00:00

  • Treatment Indications for Antidepressants Prescribed in Primary Care in France, 2006–2015

    Nov 1, 2016, 00:00

  • Rate and Healthcare Utilization (Los and Costs) of Adhesion Related Complications after Colon Resection Procedures

    Nov 1, 2016, 00:00

  • What are the Most Important Decision-Making Criteria For Innovative Health Technology Integration? A National Survey from French Hospitals Decision-Makers

    Nov 1, 2016, 00:00

  • Efectiveness and Inequality Estimation of Antihypertensive Medicinies` Utilization in Iran According to Observational Data- 2002-2011

    Nov 1, 2016, 00:00

  • Treatment Patterns And Drug-Related Costs For Patients with Psoriasis on Biologic Therapy- A Retrospective Cohort Study In Southern Italy

    Nov 1, 2016, 00:00

  • Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis- 4-Year Outcomes from the Rapid-Psa Study

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Interventions on Non-Alcoholic Fatty Liver Disease (NAFLD)- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • A New Approach to Presenting Health States in Stated Preference Valuation Studies

    Nov 1, 2016, 00:00

  • Exploring The Socioeconomic Impact Of Post Approval Change Requirements For Vaccines

    Nov 1, 2016, 00:00

  • When Should Translations of Clinical Outcome Assessments (COAS) be Considered Obsolete? Recommendations from MAPI’S Translations Life Expectancy Working Group

    Nov 1, 2016, 00:00

  • The Impact of Treatment Adherence on Clinical and Economic Outcomes in Multiple Sclerosis- Real-World Evidence from Alberta, Canada

    Nov 1, 2016, 00:00

  • Relapse Rates and Symptom Management Among Patients Receiving Natalizumab and other Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes in Spondyloarthritis Patients in Europe- A Systematic Review of the Literature

    Nov 1, 2016, 00:00

  • How are Budget Impact Considerations Captured within Economic Evaluations? A Systematic Review of the Literature Focused on Rotavirus Vaccine

    Nov 1, 2016, 00:00

  • Generic Drug Utilization Among The Elderly With Multiple Chronic Conditions In The United States

    Nov 1, 2016, 00:00

  • Development of An Alcohol Policy Model That Predicts Life Years, Qalys, and Health Care Costs Accounting for Alcohol use Disorder Identification Test

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Lanreotide Autogel 120 Mg in the Treatment of Acromegaly in Poland

    Nov 1, 2016, 00:00

  • Psychometric Validation Of Four Patient-Reported Outcome Instruments In A Diverse Sample Of Adults With Chronic Hepatitis C Virus Infection Treated With Simeprevir And Sofosbuvir

    Nov 1, 2016, 00:00

  • A UK Observational Cohort Study of Insulin Treatment Patterns and Characterisation of Insulin Users in Type 1 And Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Impact of Diabetes Management on Diabetes Control and Resource Consumption in Type 2 Diabetic Patients

    Nov 1, 2016, 00:00

  • Prevalence of Therapy-Resistant Hypercholesterolemia in High-Risk Cardiovascular Patients in Germany

    Nov 1, 2016, 00:00

  • Dimensionality Of Value- Are The Us And Europe Moving Towards Similar Or Different Definitions Of Pharmaceutical Value?

    Nov 1, 2016, 00:00

  • Treatment Resistant Depression Development From Major Depressive Disorder- A Claims Database Analysis In Japan

    Nov 1, 2016, 00:00

  • European Comparison of Spinal Surgery Hospitalizations From 2010 to 2013 According to Patient Profiles

    Nov 1, 2016, 00:00

  • Cancer Immunotherapy with Checkpoint Inhibitors is Associated with Immune-Mediated Reactions- A Pharmacovigilance Study

    Nov 1, 2016, 00:00

  • Workload Analysis Of Parenteral Nutrition Services At Ministry Of Health Hospital In Saudi Arabia

    Nov 1, 2016, 00:00

  • Assessment of CTX-1 Bone Biomarker As An Indicator of Antiresorptive Therapy Efficacy And of Persistence In A Fracture Liaison Service

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of Improving Adherence to Diabetes Treatment In Patients with Type 2 Diabetes in Spain

    Nov 1, 2016, 00:00

  • Managed Entry Agreements- Portuguese Experience

    Nov 1, 2016, 00:00

  • Comparative Analysis of Indirect Costs Associated with Chronic Spontaneous/Idiopathic Urticaria-Results From The Assure-Csu Study In 7 Countries

    Nov 1, 2016, 00:00

  • Consumer Perception of Communication with Healthcare Professionals (HCPS) and Information Clarity Concerning Newly Prescribed Medication

    Nov 1, 2016, 00:00

  • Validating The Projected Mortality Rates Used in Oncology Cost-Effectiveness Analysis- A Pitfall of Simple Benchmarking With Life Table Age-Specific Mortality Rates for A Trial Population

    Nov 1, 2016, 00:00

  • Guidance On Selecting Appropriate Methods When Considering Adjusting Overall Survival For Treatment Switch In Oncology Studies

    Nov 1, 2016, 00:00

  • The Burden of Illness of Mycosis Fungoides Cutaneous T-Cell Lymphoma- A Retrospective Cohort Study of a Commercially Insured Population in the U.S

    Nov 1, 2016, 00:00

  • An Economic Analysis on Optimal Management of Fragility Hip Fractures In Geriatric Patients Adopting The Geriatric Fracture Program

    Nov 1, 2016, 00:00

  • Application Of Quality Indicators To Enable Economic Evaluation Of Quality Improvements – A Bayesian Decision Theoretical And Value Of Information Analytical Framework

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of A Preventive Testing Strategy in Relatives of Patients with BRCA Mutated Ovarian Cancer Versus A No Test Strategy

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of Blood Cultures Among Adult Patients Admitted with Pneumonia in Tianjin, China

    Nov 1, 2016, 00:00

  • Incremental Burden of Cancer in Patients Undergoing Hepatic Resections- Results From A National Hospital Billing Data

    Nov 1, 2016, 00:00

  • Geographic, Racial, and Temporal Variations of Adherence to Screening for Cervical Cancer and HPV Vaccination in The United States, 2008-2012

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Omalizumab for the Treatment of Chronic Spontaneous Urticaria in France

    Nov 1, 2016, 00:00

  • Extra Budgetary Reimbursement Options For Innovations In The German Hospital Sector

    Nov 1, 2016, 00:00

  • Development Of Predictive Models For The Analysis Of The List Of Vital Essential And Necessary Drugs Compilation

    Nov 1, 2016, 00:00

  • A Network Meta-Analysis of Atomoxetine, Methylphenidate, Lisdexamfetamine, and Bupropion for the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents

    Nov 1, 2016, 00:00

  • Costs of Care Between Resected and Non-Resected Pancreatic Cancer Patients- Findings from a Real-World U.S. Population

    Nov 1, 2016, 00:00

  • Mathematical Model to Synthesize Natural History of Tick Borne Encephalitis and Lyme Borreliosis for the Purpose of Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • The Introduction of Etanercept Biosimilar In The Practice of A Tertiary Rheumatologic Centre In Italy- A Budget Impact Model

    Nov 1, 2016, 00:00

  • Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Axial Spondyloarthritis Patients, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 4-Year Outcomes from the Rapid-Axs ...

    Nov 1, 2016, 00:00

  • Ict Diffusion and Pharmaceuticals (Issues For Decision Tools)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab vs. Docetaxel as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Comparison of Bayesian Network Meta-Analyses in a Winbugs and SAS Framework

    Nov 1, 2016, 00:00

  • The Short-Term Health and Economic Burden of Gestational Diabetes Mellitus in Italy

    Nov 1, 2016, 00:00

  • Evaluation of Methodological Variations in the Event Simulation Approaches of Published Health Economic Models in Obesity Prevention and Therapy

    Nov 1, 2016, 00:00

  • The Economic Burden of Four Heart Conditions in Brazil

    Nov 1, 2016, 00:00

  • Network Meta-Analysis To Assess The Relative Efficacy of Empagliflozin Monotherapy Over 24, 52, And 76 Weeks In Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Is There a Justification to Fullfill the Gap in Clinical Pathway of Inflammation and Itching Treatment in Poland - Cost-Utility Analysis (CUA) of Mometasone Furoate Ointment

    Nov 1, 2016, 00:00

  • Nothing Ventured, Nothing Gained – Is The Innovation Fund The Catapult to A New Generation of Care Concepts and A Competitive Market in Health Care in Germany?

    Nov 1, 2016, 00:00

  • Real-World Outcomes and Resource Utilisation Following Onabotulinumtoxina Treatment For Severe Lower Limb Focal Spasticity in Adults – Database Analysis at An Australian Hypertonicity Clinic

    Nov 1, 2016, 00:00

  • Was the Consistency of Data Improved after Separating the Better than Health (BTD) and Worse than Death (WTD) Tasks and Implementing a Feedback Module (FB) in Composite Time Trade off (CTTO) Exercise?

    Nov 1, 2016, 00:00

  • Management and Outcomes of Acute Kidney Injury

    Nov 1, 2016, 00:00

  • The Impact of the Difference in Natural History Models on the Cost-Effectiveness of Antiviral Agents for Patients with Genotype 1 Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • Is Big Data in Healthcare about Big Hope or Big Hype? Early Health Technology Assessment of Big Data Analytics in Healthcare

    Nov 1, 2016, 00:00

  • What Is The Hospital Economic Burden Of Hiv In France? Results from an analysis of the national french medical information system database

    Nov 1, 2016, 00:00

  • Reliability and Validity of the Health Assessment Questionnaire (Haq) in Patients with Spondyloarthritis

    Nov 1, 2016, 00:00

  • Drug Utilization Study of Antibiotics in A Secondary Care Referral Hospital

    Nov 1, 2016, 00:00

  • The Impact Of Cost Sharing Arrangements In The Use Of Health Care Services During The Economic Crisis In Greece And The Attitudes Of Citizens

    Nov 1, 2016, 00:00

  • The Benefits of Earlier Treatment with Paritaprevir/Rotanavir/Ombitasvir with or without Dasabuvir in Ireland

    Nov 1, 2016, 00:00

  • Health Status in Patients with Severe Haemophilia a According to Treatment Regimen and Age

    Nov 1, 2016, 00:00

  • The Therapeutic Indication of Capsule and Injectable Etoposide To The Treatment of Osteosarcoma

    Nov 1, 2016, 00:00

  • Priority Setting of Medical Device for Patient Safety in Korean Hospitals

    Nov 1, 2016, 00:00

  • Assessing The Cost-Effectiveness of Secukinumab Compared To Tnf Inhibitors As Second Line Biologic Treatment In Psoriatic Arthritis

    Nov 1, 2016, 00:00

  • A Risk-Benefit Analysis of Key Performance-Based Risk Sharing Agreements (PBRSAS) in the EU and US (2002-2016)

    Nov 1, 2016, 00:00

  • Measuring the Relationship between Hospital Costs and Quality of Care- An Example of Acute Myocardial Infraction in Edmonton, Alberta, Canada

    Nov 1, 2016, 00:00

  • Hospitalization Cost and Length of Stay Associated with HPV-Related Diseases

    Nov 1, 2016, 00:00

  • Determinants of The Impact of The Economic Crisis on General and Oral Health in Greater Athens Area Greece

    Nov 1, 2016, 00:00

  • Clinical Effectiveness of Ranibizumab And Aflibercept For Central RVO- A Retrospective Cohort Study Using Electronic Medical Records From The USA

    Nov 1, 2016, 00:00

  • Clinical Effectiveness Telepsychotherapy for Depression Disorder- A Systematic Review

    Nov 1, 2016, 00:00

  • Costs And Quality of Life of Low Back Pain- A Multi-Register Based National Treatment Pathway Model In Sweden

    Nov 1, 2016, 00:00

  • A Conceptual Framework of Baseline Equity for Rural Basic Medical Insurance in China- Based on Policy Process Theory

    Nov 1, 2016, 00:00

  • Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis For The Treatment Of Primary Immunodeficiency Disease (Pidd) In The Mexican Social Security Institute In 2016

    Nov 1, 2016, 00:00

  • Cost Minimisation Analysis Of Follitropin Delta Versus Follitropin Alfa In Assisted Reproductive Technologies (Ivf/Icsi) In The United Kingdom

    Nov 1, 2016, 00:00

  • Acceptability of Electronic Patient Reported Outcomes In Clinical Care of HIV

    Nov 1, 2016, 00:00

  • Comparison of Three Generic Utility Instruments In Patients With Renal Disease

    Nov 1, 2016, 00:00

  • Exercise and Factors Influence Mental Health Of Undergraduated Students At Burapha University In 2014

    Nov 1, 2016, 00:00

  • Health Technology Assessment in Argentina- At what Point in the Life-Cycle of Technologies are they Requested

    Nov 1, 2016, 00:00

  • A Network Metanalysis To Compare Biologic Agents In The Treatment of Non-Radiographic Axial Spondyloarthritis

    Nov 1, 2016, 00:00

  • The Increasing Role of Wearable Digital Technology in Disease Management - An Assessment of the Opportunities and Challenges from a Multi-Stakeholder (Patient, Payer, Physician, Manufacturer) Perspective

    Nov 1, 2016, 00:00

  • Pessoa Study – Evaluating The Burden of Psoriasis In Portugal From The Patients’ Perspective (A Patient Reported Outcomes Analysis)

    Nov 1, 2016, 00:00

  • Willingness to Pay For A Quality-Adjusted Life Year of Outpatients with Cardiovascular Diseases

    Nov 1, 2016, 00:00

  • Comparison of Informal Caregiving Time Required by Alzheimer's Disease Patients and Mild Cognitive Impairment Patients

    Nov 1, 2016, 00:00

  • Racial Disparities In Access To Pharmacy And Its Services In Pennsylvania

    Nov 1, 2016, 00:00

  • Meta-Analysis of Newer Anti-Epileptic Drugs for Treatment of Partial Epilepsy in Children

    Nov 1, 2016, 00:00

  • Getting Medical Innovation to Patients in Developing Countries - A Systemic Approach to Setting Price and Access

    Nov 1, 2016, 00:00

  • Healthcare Resource Use Alongside Novel Treatments for Advanced Melanoma in the Netherlands

    Nov 1, 2016, 00:00

  • The Relationship Between Target Joints And Non-Drug Direct Costs In Severe Haemophilia

    Nov 1, 2016, 00:00

  • The Effects of Continues Glucose Monitoring System on Patient Outcomes and Associated Costs

    Nov 1, 2016, 00:00

  • Detection and Analysis of Therapy Lines and Other Event Sequences in Claims Data

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of A Flash Glucose Monitoring System for Type 2 Diabetes (T2DM) Patients Receiving Intensive Insulin Treatment in Europe

    Nov 1, 2016, 00:00

  • A 12-Week Cost Analysis to Compare Fluticasone Furoate/Vilanterol And Beclomethasone Dipropionate/Formoterol In The Treatment of Mild-To-Moderate Asthma

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Bevacizumab Compared to Cetuximab and Panitumumab in First-Line Treatment of Kras Wild-Type Metastatic Colorectal Cancer in France

    Nov 1, 2016, 00:00

  • Adherence to Osteoporosis Drugs and Clinical Outcomes Among Osteoporosis Patients with Different Risk Profiles

    Nov 1, 2016, 00:00

  • A Patient Survey Regarding Risk of Opioid Abuse- Results of A Pilot Study

    Nov 1, 2016, 00:00

  • Analysis of Hta Requirements Across 10 Emerging and Developed Countries

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis- A Comparison Between Preset Artery Blood Samplers and Disposable Syringes in Arterial Blood Sampling

    Nov 1, 2016, 00:00

  • Cost Utility of Transfer Factor In The Treatment of Recurrent Infection`S Episodes In Adult And Pediatric Subjects From A Final Results From Multicentre Observational Study

    Nov 1, 2016, 00:00

  • Using Orthogonal Design in Selecting Health States for the Construction of EQ-5D-3L Value Set

    Nov 1, 2016, 00:00

  • Bio-Similar Or Different? – Understanding The Payer Perspective

    Nov 1, 2016, 00:00

  • In-Hospital Mortality and Complications Following Surgical Resection of Glioblastoma

    Nov 1, 2016, 00:00

  • Use of Novel Health-Related Quality of Life Measures to Assess The Effect of Metamorphopsia Symptoms In Patients with Vitreomacular Traction, With or Without Macular Hole- The Memo Study

    Nov 1, 2016, 00:00

  • Comorbidities in HIV-1- A Literature Review of the Associations Between Patient- and Disease-Related Factors and Non-Aids Related Comorbidities (NARCS)

    Nov 1, 2016, 00:00

  • The Economic Impact of Influenza-Like Illness on Families Living in the UK Demonstrated by the Collection of Online Data

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Tips Procedures with Expanded Polytetrafluoroethylene (EPTFE) Covered Stent-Grafts Compared to Large Volume Paracentesis in Patients with Refractory Ascites – A Spanish Scenario

    Nov 1, 2016, 00:00

  • Estimating The Economic and Clinical Benefits of Mirabegron Versus Antimuscarinics for The Treatment of Overactive Bladder (OAB) in The United Kingdom (UK)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Lipegfilgrastim in Prophylaxis of Febrile Neutropenia in Cancer Patients

    Nov 1, 2016, 00:00

  • Literature Review on Hospital Costs for Patients Undergoing Gastrectomy

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Using Everolimus or Axitinib in Patients with Metastatic Renal Cell Carcinoma WHO Have Failed to Use of Pazopanib or Sunitinib in First-Line Treatment

    Nov 1, 2016, 00:00

  • Societal Implications of Medical Insurance Coverage for Imatinib as First-Line Treatment of Chronic Myeloid Leukaemia in China- A Cost Effectiveness Analysis

    Nov 1, 2016, 00:00

  • EFFECTIVENESS OF THE TRX SUSPENSION TRAINER IN PEOPLE WITH OSTEOARTHRITIS

    Nov 1, 2016, 00:00

  • The Societal Impact Of Natalizumab Treatment In The Italian Relapsing-Remitting Multiple Sclerosis Clinical Practi The Tysabri® Pharmacoeconomics (Type) Study

    Nov 1, 2016, 00:00

  • Comparison Of The Relationship Between Socio-Economic Status And Health-Related Quality Of Life Amongst Atopic Dermatitis Patients Across Different Healthcare Systems

    Nov 1, 2016, 00:00

  • Nintedanib Cost-Effectiveness In Idiopathic Pulmonary Fibrosis In The UK

    Nov 1, 2016, 00:00

  • Investigating Performance Indicators and Service Quality Improvement in an Outpatient Cardiology Department

    Nov 1, 2016, 00:00

  • The Outcomes of A Pharmaceutical Care Assistance Program in A Romanian Community Pharmacy

    Nov 1, 2016, 00:00

  • Adoption of Transcatheter Mitral Valve Repair in Germany- Utilization Patterns and Case Volumes Compared to Mitral Valve Surgery in the Period 2010-2014

    Nov 1, 2016, 00:00

  • The Effectiveness of Lean Body Mass Analysis Using Dual Energy X-Ray Absorptiometry (DEXA) for Diagnosis of Sarcopenia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Continuous Intraduodenal Levodopa Intestinal Gel Infusion in the Treatment of Advanced and Severe Forms of Parkinson's Disease

    Nov 1, 2016, 00:00

  • Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spond ...

    Nov 1, 2016, 00:00

  • Work Productivity Activity Impairment Loss of Patients with HER2 Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Well-Being- What Is It, How Does it Compare to Health and What are the Implications of Using it to Inform Health Policy?

    Nov 1, 2016, 00:00

  • Autoinjector Preference Among Patients with Multiple Sclerosis- Results From A National Survey

    Nov 1, 2016, 00:00

  • Linguistic Validation of the Injection-Treatment Acceptance Questionnaire (I-TAQ)

    Nov 1, 2016, 00:00

  • New Data on the Burden of Abnormal Pap Smears and Hospitalised Pre-Cancerous Lesions in France (EGB AND PMSI DATABASES ANALYSIS)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Acupuncture Treatment In Mental Disorder- A Systematic Review

    Nov 1, 2016, 00:00

  • Developing HTA Guidelines for Rare Disease Therapies - an Industry Perspective

    Nov 1, 2016, 00:00

  • The Invariance Analysis Of Sf12v2- ¿Are Comparable The Quality Of Life Results Of Men And Women?

    Nov 1, 2016, 00:00

  • Pharmaceutical Pricing Strategies In Developing Countries- A Systematic Review

    Nov 1, 2016, 00:00

  • Analysis Of Influenza Vaccination Effectiveness In General Practitioner

    Nov 1, 2016, 00:00

  • Predicting Orphan Designation And Marketing Authorisation Based On A Review Of The European Medicines Agency Orphan Disease Register

    Nov 1, 2016, 00:00

  • Evaluation of Supportive Care in the Cancer Patients on Chemotherapy in a Developing Country- A Comparision of Clinical Practice with Standard Guidelines

    Nov 1, 2016, 00:00

  • Health Related Quality of Life Scores in Breast Cancer Survivor Women with and without Breast Reconstruction Surgery

    Nov 1, 2016, 00:00

  • Medication Errors Avoided by Medication Reconciliation Process at Female Surgery Ward in Ramathibodi Hospital, Thailand

    Nov 1, 2016, 00:00

  • Comparative Analysis Of Medication Possession Ratio Measures For Adherence To Single-Medication

    Nov 1, 2016, 00:00

  • Cancer Associated Medical Spending- US National Data Between 2000 and 2013

    Nov 1, 2016, 00:00

  • Deep Brain Stimulation Compared to Device-Aided Infusion Therapies for Parkinson’s Disease with Early Motor Complications- A UK Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Impact of Etanercept Biosimilar Launches on Healthcare Spending- A UK Budget Impact Model For The Treatment of Rheumatoid Arthritis And Chronic Plaque Psoriasis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rotavirus Vaccination in Hangzhou, China- A Comparison Between two Vaccines

    Nov 1, 2016, 00:00

  • Critical issues influencing cost-effectiveness analyses of pneumococcal vaccine strategy for elderly in japan

    Nov 1, 2016, 00:00

  • Breast Cancer in China- Room for Improved Screening

    Nov 1, 2016, 00:00

  • Burden of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS)

    Nov 1, 2016, 00:00

  • Role of Tiered Pricing Policy in Improving Access to Medicines in India

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Ombitasvir/Paritaprevir/Ritonavir With Or Without Dasabuvir For The Treatment Of Chronic Hepatitis C Patients Infected With Genotype 1 Or 4 In France

    Nov 1, 2016, 00:00

  • Is the Orphanage Filling Up? Projecting the Growth and Budget Impact of Orphan Drugs in Europe

    Nov 1, 2016, 00:00

  • Epidemiology, Treatment Pathways and Costs of Cancers Potentially Related to HPV Infection in France

    Nov 1, 2016, 00:00

  • Free Essential Medicines Through Public Health Facilities in Nepal- A Qualitative Study

    Nov 1, 2016, 00:00

  • Real Life Drug Utilization and Biologics Effectiveness in Patients With Crohn's Disease – A Population-Based Study in Taiwan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal

    Nov 1, 2016, 00:00

  • A Study Comparing the Evolution of Different Proceeses for Patient Input in Different European HTA Systems Since 2011

    Nov 1, 2016, 00:00

  • Assessing Patient Preference for Insulin Intensification in France

    Nov 1, 2016, 00:00

  • A Systematic Literature Review to Identify Clinical Drivers in Cost-Effectiveness Analyses in T2DM Patients Uncontrolled on Current Therapies

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Viacoram for The Treatment of Hypertension in Italy

    Nov 1, 2016, 00:00

  • What is Real-World Data?- A Review of Definitions Based on Literature Stakeholder Interviews

    Nov 1, 2016, 00:00

  • Feasibility, Reliability and Validity of The Decision Tool Unipolar Depression (DTUD) In Identifying Patients with Major Depressive Disorder in Need of Highly Specialized Care

    Nov 1, 2016, 00:00

  • Positive Impact of Indacaterol Launch on Guidelines Compliance And Consequences on COPD Daily Treatment Cost In France

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Nivolumab for the Treatment of Metastatic Melanoma in Chile

    Nov 1, 2016, 00:00

  • Using Analytic Hierarchy Process to Weight Patient-Relevant Outcomes in the Treatment of Psoriasis for Calculating the Patient Benefit Index

    Nov 1, 2016, 00:00

  • Review Of National Policies For Rare Diseases Across Eu Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Gazyvaro in Association to Chlorambucil for Patients with Chronic Lymphocytic Leukemia When Full-Dose Fludarabine is Unsuitable in France

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of First-Line S-1 Therapy for Metastatic Breast Cancer Patients Compared with Taxanes- An Analysis Based on the Randomized Phase III Select BC Trial

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Evaluating Vortioxetine Versus Venlafaxine XR and Agomelatine in the Treatment of Major Depressive Disorder in Taiwan

    Nov 1, 2016, 00:00

  • A Review of Pharmeceutical Policies in Response to Economic Crisis and Sanctions

    Nov 1, 2016, 00:00

  • Systematic Review, Meta-Analysis, and Cost-Effectiveness Model of Invasive Versus Non-Invasive Strategy for Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) in Patients with Prior Coronary Artery Bypass Graft (CABG)

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns Among Patients with Ovarian Cancer- An Analysis of a Large us Electronic Health Records Database

    Nov 1, 2016, 00:00

  • Economic Impact of Fentanyl HCL Iontophoretic Transdermal System Versus IV PCA In Acute Pain Management Following Surgery In The United Kingdom, Germany And Sweden

    Nov 1, 2016, 00:00

  • • Analysis of The Factors Affecting Parents’ Medication Adherence In Asthmatic Children Using Expectation Confirmation Theory

    Nov 1, 2016, 00:00

  • Hyperbolic Discounting of Effects in Economic Evaluations

    Nov 1, 2016, 00:00

  • Evaluation of The Cost Saving Potential of Introducing Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Three Regions In Italy

    Nov 1, 2016, 00:00

  • Utilisation of Antithrombotic Drugs in Slovakia

    Nov 1, 2016, 00:00

  • Diabetic Macular Edema, Budget Impact Analysis from the Perspective of the Algerian Public Health System

    Nov 1, 2016, 00:00

  • Retrospective Study of Frequency and Cost of Multiple Myeloma (MM) Complications and Treatment Related Adverse Events (AES)

    Nov 1, 2016, 00:00

  • A First Cost-Effectiveness Analysis Based on Real Life Clinical Outcomes of Bevacizumab+ Paclitaxel Compared to Paclitaxel Among French Patients with HER2- Metastatic Breast Cancer in First Line of Treatment

    Nov 1, 2016, 00:00

  • Financial Impact of Intraviteal Ranibizumab or Aflibercepte for Neovascular Age-Related Macular Degeneration and for Macular Edema Secondary to Central Retinal Vein Occlusion Coverage for a Health Care System of Public Employees Located in ...

    Nov 1, 2016, 00:00

  • A Health Technology Assessment of Home-Based Haemodialysis in Esrd Patients

    Nov 1, 2016, 00:00

  • The Economic Value of Rapid Deployment Aortic Valve Replacement Via Full Sternotomy

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation in The Guangdong Healthcare Setting in China

    Nov 1, 2016, 00:00

  • Number Of Patients In Physiotherapy Services Within Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00

  • The Importance of Conitec Recommendation about Analogues Insulins of The Treatment of Diabetes Type 1

    Nov 1, 2016, 00:00

  • Clinical Evaluation of Amritha Guggulu in the Management of Gout

    Nov 1, 2016, 00:00

  • Treatment Persistence and Discontinuation Risk of Typical Depot and Atypical Long-Acting Antipsychotics in Patients with Schizophrenia in Poland

    Nov 1, 2016, 00:00

  • Rates And Predictors Of Short Term Disability Claims Among Migraine Patients In The Us

    Nov 1, 2016, 00:00

  • Evaluation Of The Value Of Pharmaceutical Products In Taiwan

    Nov 1, 2016, 00:00

  • Modelling The Economic Impact of Implementing Treatment-Free Remission (TFR) In Philadelphia+ (PH+) Chronic Myelogenous Leukemia In Chronic Phase (CML-CP) Patients Treated In First Line (1l) With The Tyrosine Kinase Inhibitors (TKI)- Imatin ...

    Nov 1, 2016, 00:00

  • Concordance of Health Technology Assessment Recommendations of Diabetes, Hepatitis, Oncology and Epilepsy Pharmaceutical Products by Five Agencies within Europe- An Interrater Reliability and Association Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Acupuncture Versus Standard Care For Pelvic And Low Back Pain In Pregnancy- An Analysis of The Game Randomized Trial

    Nov 1, 2016, 00:00

  • Informal Care and Productivity Losses are Important in Advanced Cutaneous Melanoma- Results of the Dutch Melanoma Treatment Registry

    Nov 1, 2016, 00:00

  • The Adoption Trends of Robotic-Assisted Benign Hysterectomy in United States From 2008 to 2014

    Nov 1, 2016, 00:00

  • The Choice Between HIP Prosthetic Implants in Total HIP Replacement- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Targeted Treatments for Pulmonary Arterial Hypertension (PAH) In Patients Receiving Active Treatments without Adequate Response

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab for the Treatment Of Advanced Non-Squamous Non-Small Cell Lung Cancer (Nsclc) In Saudi Arabia

    Nov 1, 2016, 00:00

  • France-Spain Comparison of Hospital Delivery Mode Between 2006 And 2014 According Comorbidity Profiles of Patients

    Nov 1, 2016, 00:00

  • Review of Economic Evaluation of Saxagliptin in Type2 Diabetes in China

    Nov 1, 2016, 00:00

  • Balancing Commercial Confidentiality with Accountability- A Proposal for Enhanced Disclosure of Cost-Effectiveness Decisions

    Nov 1, 2016, 00:00

  • Economic Burden of Maintaining Vascular Access Patency in Patients with Hemodialysis Fistulas - A National Population-Based Study

    Nov 1, 2016, 00:00

  • Irrational Use of Antibiotics in Turkey

    Nov 1, 2016, 00:00

  • What Motivates Mothers To Pay For A Vaccine Against Children’s Diarrhea? Preferences for vaccines against children’s diarrheal illness among mothers in poland and hungary

    Nov 1, 2016, 00:00

  • Budget Impact Estimation of Changes In Reimbursement of Basal Insulin Therapies in Hungary

    Nov 1, 2016, 00:00

  • Global Prevalence Estimates of Transthyretin Familial Amyloid Polyneuropathy (ATTR-FAP)- A Systematic Review and Projections

    Nov 1, 2016, 00:00

  • The Role of Budget Impact on HTA Rejection of Oncology Drugs in Romania

    Nov 1, 2016, 00:00

  • Impact of State Mandated Queries of The Prescription Drug Monitoring Programs on Opioid And Non-Opioid Drug Related Adverse Effects- A Difference In Difference Approach

    Nov 1, 2016, 00:00

  • Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries

    Nov 1, 2016, 00:00

  • Ofatumumab As A Combination Therapy Versus Other Treatment Regimens in Patients with Untreated, Relapsed or Refractory Chronic Lymphocytic Leukaemia- A Systematic Review of Randomised Controlled Trials

    Nov 1, 2016, 00:00

  • Economic Value of Eptfe Stent-Grafts Compared to Balloon Angioplasty for Treating Thrombosed and Dysfunctional Arteriovenous Grafts in England

    Nov 1, 2016, 00:00

  • To Treat or Watch? Identifying Drivers of Decisions for Patients with GEP-NET Using Reflective Multi-Criteria Decision Analysis

    Nov 1, 2016, 00:00

  • Evaluation of Attitude and Perception of Retail Pharmacists Towards Patient Safety

    Nov 1, 2016, 00:00

  • Cone Beam Computed Tomography use in Overdenture Abutments Examination- Risk Benefit Analysis

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis on Hepatic Carcinoma Patients with Hepatitis C

    Nov 1, 2016, 00:00

  • Inpatient Treatment Cost of Stroke- An Analysis in Ho Chi Minh City 115 People's Hospital, Vietnam

    Nov 1, 2016, 00:00

  • Mapping the Prescription Trend for Rheumatoid Arthritis in Mumbai, India

    Nov 1, 2016, 00:00

  • The Multidisciplinary Risk Assessment and Management Program – Diabetes Mellitus (Ramp-Dm) was Cost-Effective for Managing Patients with Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of The Introduction Of Biosimilars In A Belgian Tertiary Care Hospital- A Simulation

    Nov 1, 2016, 00:00

  • Implications of Total Budget Impact on Oncology Drug Pricing in The us And EU5

    Nov 1, 2016, 00:00

  • Boosting a Modeller's Armoury- Pursuing Realistic and Efficient Competing Risk Health Economic Models (HEMS)

    Nov 1, 2016, 00:00

  • Supply-Side and Demand-Side Policies for Biosimilars- An Overview in 10 European Member States

    Nov 1, 2016, 00:00

  • Assessment of Community Pharmacy Services in Malaysia- Perspectives from Community Pharmacists, General Practitioners, Consumers and Health Policy Stakeholders

    Nov 1, 2016, 00:00

  • Pharmaceutical Reimbursement Of Innovative Medicinal Products In Belgium

    Nov 1, 2016, 00:00

  • Epidemiological Estimation and Flow of Patients with Advanced Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy in Spain

    Nov 1, 2016, 00:00

  • Factors Associated with 90-Day or 180-Day Long-Term Use of Anxiety-Hypnotic Prescriptions and Economic and Safety Outcomes- A Retrospective Cohort Study

    Nov 1, 2016, 00:00

  • A Real Concern Or Just A Hype? – Evidence On Negative Clinical Consequences Of Switching From Originator To Biosimilar Based On A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Results from a Model to Forecast The Current and Future Number of Patients Eligible for Treatment of Refractory Advanced Non-Small Cell Lung Cancer (NSCLC) in France, Germany, Italy and Spain

    Nov 1, 2016, 00:00

  • Incremental Direct And Indirect Costs Associated With Migraine In The Us

    Nov 1, 2016, 00:00

  • Assessment Of Price Of Essential Medicines In India

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/Valsartan for Heart Failure Patients with Reduced Ejection Fraction in Italy

    Nov 1, 2016, 00:00

  • Inpatient Treatment Cost of Post-Stroke- An Analysis in Hospital of Occupational Diseases and Rehabilitation, Vietnam

    Nov 1, 2016, 00:00

  • Prevalence, Perception And Reasons For Self Medication

    Nov 1, 2016, 00:00

  • Effectiveness of Photodynamic Therapy in Patients with Localized Esophageal Cancer

    Nov 1, 2016, 00:00

  • Systematic Review of Cost-Effectiveness Analysis (CEA) of The Cell Free DNA (CFDNA) / Non-Invasive Prenatal Test (NIPT) for Trisomy 21 (T21) Screening

    Nov 1, 2016, 00:00

  • The Association Between Parenting Stress And The Child’s Quality of Life Among Parents of Asthmatic Children

    Nov 1, 2016, 00:00

  • Utilisation and Expenditure Beyond HTA- A Case Study of Lidocaine 5% Medicated Plaster

    Nov 1, 2016, 00:00

  • prevalence of Anticholinergic Drug Use in Older Adults With Dementia

    Nov 1, 2016, 00:00

  • Development of a Guidance on the Implementation and use of EORTC Instruments in Electronic Applications

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment of Certolizumab Pegol In Adults With Axial Spondyloarthritis In Mexico

    Nov 1, 2016, 00:00

  • Are We Indeed Fast Adopters As We Claim To Be? An Analysis Of The Time Interval From Regulatory Approval To Coverage And Reimbursement In The National List Of Health Services In Israel

    Nov 1, 2016, 00:00

  • Predicting Response To Anti-Vascular Endothelial Growth Factor Treatment Using Electronic Medical Record Data In Eyes With Neovascular Age-Related Macular Degeneration

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications on Smoking Cessation and Relapses Among Elderly Smokers

    Nov 1, 2016, 00:00

  • Developing and Testing A Stated-Preference Instrument to Prioritize Treatment Goals Among Patients with Recent Onset Schizophrenia

    Nov 1, 2016, 00:00

  • Short And Long Term Costs Associated With Different Cardiovascular Events In Belgium

    Nov 1, 2016, 00:00

  • Adjusted Comparison of Daratumumab Monotherapy Versus Real-World Historical Control Data From The Czech Republic in Heavily Pre-Treated and Highly Refractory Multiple Myeloma Patients

    Nov 1, 2016, 00:00

  • Management of Patients with Statin Intolerance in Japan, South Korea and Taiwan- Comparison of Results From A Clinician Survey

    Nov 1, 2016, 00:00

  • Medication Reconciliation- A Tool for Better Patient Care

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab in Patients with Advanced or Metastatic Renal Cell Carcinoma in Portugal

    Nov 1, 2016, 00:00

  • Cost Assessment Of Antibiotics Use In A Hospital In The Dominican Republic

    Nov 1, 2016, 00:00

  • Prices And Affordability Of Reimbursed Pharmaceuticals- A European Cross-Country Study

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Cementless Versus Cemented Prostheses for Total HIP Arthroplasty From A UK Hospital Perspective

    Nov 1, 2016, 00:00

  • Scientific Epidemiology and Health Economics- A Retrospective Analysis on Pesticide Consumption and Survivors in Telangana State-India

    Nov 1, 2016, 00:00

  • Understanding the Utility Value of Patients with Heavily Pre-Treated Multiple Myeloma

    Nov 1, 2016, 00:00

  • Attributes Defining Patient Engagement And Centeredness In Health Care Research And Practi A Framework Developed By The Ispor Patient-Centered Special Interest Group

    Nov 1, 2016, 00:00

  • Access to Anti-Cancer Drugs In India- Is There a Need to Revise Reimbursement Policies?

    Nov 1, 2016, 00:00

  • Current Reimbursement Situation of Advanced Therapy Medicinal Products (ATMP) in Germany- Which Strategy to Secure Adequate Funding?

    Nov 1, 2016, 00:00

  • Private and Catastrophic Health Expenditure of Patients with Early and Locally Advanced Breast Cancer in Greece

    Nov 1, 2016, 00:00

  • Factors Influencing the Pharmacokinetics of Sunitinib and its Active Metabolite in MRCC Patients Receiving an Attenuated Sunitinib Dosing Regimen

    Nov 1, 2016, 00:00

  • patient Characteristics and Treatment Patterns of Venous Thromboembolism (Vte) Among Hospitalized Patients in China- an Analysis of Electronic Medical Record Data

    Nov 1, 2016, 00:00

  • A Systematic Review of Cardiovascular Event Utilities in Asia

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Panitumumab Compared with Cetuximab in the First-Line Treatment of Wild-Type RAS Metastatic Colorectal Cancer Patients in Brazil

    Nov 1, 2016, 00:00

  • Economic Evaluation of Tocilizumab Vs Abatacept In Methotrexate-Experienced Patients with Rheumatoid Arthritis In Italy

    Nov 1, 2016, 00:00

  • The Probabilistic Efficiency Frontier- A Value Assessment Of Treatment Options In Hepatitis C

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Using Factor VII + Von Willebrand Factor In Treatment of Patients with Von Willebrand Disease

    Nov 1, 2016, 00:00

  • Economic Evaluation of Cancer Medicines Usage at Uganda Cancer Institute

    Nov 1, 2016, 00:00

  • Relapse Rates and Healthcare Resource use of Therapy Persistent And Non-Persistent Multiple Sclerosis Patients In Germany – A Real World Analysis

    Nov 1, 2016, 00:00

  • Anticipated Impact of EU5 Payer Policy on Prescribing of Novel Biologic Therapies In Asthma

    Nov 1, 2016, 00:00

  • Cross-Cultural Adaptation of the Zarit Caregiver Interview for Alzheimer's Disease (ZCI-AD) and the Caregiver Global Impression Scales in 13 Languages

    Nov 1, 2016, 00:00

  • The Behaviour Of Pharmacists In Public Pharmacies In Relation To The Cold Regime Drugs

    Nov 1, 2016, 00:00

  • Economic Burden of Schizophrenia in Italy- A Probabilistic Cost of Illness Analysis

    Nov 1, 2016, 00:00

  • European Regulators and Payers Initiatives for Drug Access- Collaborations or Divergences?

    Nov 1, 2016, 00:00

  • Examining The Association Between Corticosteroid Exposure and New Onset Type 2 Diabetes Among Commercially Insured Copd Patients In The US

    Nov 1, 2016, 00:00

  • Health Related Quality of Life for Disease Population in China- A Systematic Review

    Nov 1, 2016, 00:00

  • Burden of Disease And Management of Mesothelioma In Fran A National Cohort Analysis

    Nov 1, 2016, 00:00

  • Evaluation of Antibacterial and Cytotoxic Effects of Gymnema Sylvestre R.BR. Species Cultivated in Pakistan Against Common Resistant Pathogens

    Nov 1, 2016, 00:00

  • Economic Burden of Heart Failure in Chinese Population

    Nov 1, 2016, 00:00

  • The Impact Of Regional Legislative Measures On The Prescription Of Off-Patent Medicines

    Nov 1, 2016, 00:00

  • Association Between Orphan Drug Prices and Therapeutic Area

    Nov 1, 2016, 00:00

  • Insights for Care- Comparison of Healthcare Utilisation and Cost Impact of Managing Diabetes Patients with Hypoglycaemia to Patients with Heart Failure or Stroke Using Real-World Evidence Data from an Urban Healthcare System in Birmingham, ...

    Nov 1, 2016, 00:00

  • “Causal Cascade” Among Outcomes in Non-Small Cell Lung Cancer- Assessing The Direct and Indirect Effects of Symptoms on Health-Related Quality of Life (HRQL) Outcomes

    Nov 1, 2016, 00:00

  • A Dynamic Simulation to Investigate Health Economic Impact of a Pulmonary Artery Pressure Sensor for Heart Failure Telemonitoring

    Nov 1, 2016, 00:00

  • Subatmospheric Pressure Therapy Efficiency for the Treatment of Pressure Ulcers- A Health Techonology Assessment

    Nov 1, 2016, 00:00

  • Application of Healthcare Failure Mode Effect Analysis in Improving Patient Education at an Outpatient Department af a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Analysis of Rational Medication for Cardiovascular Diseases in Fujian, China

    Nov 1, 2016, 00:00

  • Estimating the Impact of Direct-to-Consumer Advertising of Pharmacy Only Medicine Using Discrete Choice Experiments

    Nov 1, 2016, 00:00

  • Special Considerations and Patient Access Schemes for Oncology by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries

    Nov 1, 2016, 00:00

  • Linguistic Validation Of The Finnish Version Of The Modified Mobility Section Of The Prosthesis Evaluation Questionnaire

    Nov 1, 2016, 00:00

  • Economic Assessment of Routine Oncotype DX Testing of Estrogen Receptor Positive (ER+) Early Breast Cancer (EBC) Patients with Grade 2 Tumours in Czech Republic

    Nov 1, 2016, 00:00

  • Length of Stay, Costs and Mortality Attributable to Clostridium Difficile Infections in 13 Belgian Hospitals

    Nov 1, 2016, 00:00

  • Differential Patterns of Persistent Opioid Use in Patients with Cancer and Non-Cancer Pain

    Nov 1, 2016, 00:00

  • Pegaspargase Versus Asparaginase In Childhood Acute Lymphoblastic Leukemia- A Cost-Minimization Analysis In France

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major European Markets- Systematic Evaluation in 10 EU Countries

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results From a Survey of Clinicians in Japan

    Nov 1, 2016, 00:00

  • Colorectal Cancer Treatment Costs in Estonia

    Nov 1, 2016, 00:00

  • Trading-Off Quality of Life and Survival Time – Feasibility of Web-Based Discrete Choice Experiments For QLU-C10D Utility Elicitation in Cancer Patients

    Nov 1, 2016, 00:00

  • Hospitalization Costs Associated with Crohn's Disease and Ulcerative Colitis in Belgium

    Nov 1, 2016, 00:00

  • Development of a Global Model for the Economic Evaluation of Pharmacogenomics Tests for Early-Stage Breast Cancer Treatment

    Nov 1, 2016, 00:00

  • Policy Objective of Generic Medicines from the Investment Perspective- The Case of Clopidogrel

    Nov 1, 2016, 00:00

  • An Economic Model of Advance Care Planning- A Cost Effective Intervention for People with Dementia

    Nov 1, 2016, 00:00

  • Breast Cancer In Japan- Room For Improved Screening

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Ranibizumab Compared to Dexamethasone in Patients with Retinal Vein Occlusion (RVO) from A Portuguese Health Care Perspective

    Nov 1, 2016, 00:00

  • Clinical and Economic Outcomes of Venous Thromboembolism (VTE) Among Hospitalized Patients in China- An Analysis of Electronic Medical Record Data

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Ruxolitinib Versus Best Available Therapy For The Treatment of Myelofibrosis From Public Health Perspective In Chile

    Nov 1, 2016, 00:00

  • The Therapeutic Indication of Injectable Bevacizumab to The Treatment of Age-Related Muscular Degeneration

    Nov 1, 2016, 00:00

  • Modelling the Cost-Effectiveness of Treatment Strategies in Chronic Lymphocytic Leukaemia, Follicular Lymphoma and Multiple Myeloma- A Review and Critical Appraisal of the Published Literature

    Nov 1, 2016, 00:00

  • Further Validation of the Haemopref in a Real-World Setting

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Injecting A "Dexamethasone Ropivacaine" Mixture Subcutaneously In The Management of Traumatic Bone Surgeries of The Forefoot

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab + Ipilimumab in First-Line Treatment of Advanced Melanoma

    Nov 1, 2016, 00:00

  • Long-Term Health-Related Economic Burden of Adult Congenital Heart Diseases in Hong Kong

    Nov 1, 2016, 00:00

  • Investigating the Effects of Testing and Adjusting for Nonlinearity using Categorization in Prediction Models with Costs as Outcome

    Nov 1, 2016, 00:00

  • Generic drugs- do they offer the same safety and efficacy as originator medicines? -perceptions and attitudes of final year pharmacy students in greece

    Nov 1, 2016, 00:00

  • A Comparison of EQ-5D-3L Index Scores Using Foreign Value Sets for Indonesian Sample with Cervical Cancer

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Comprehensive Medication Review (CMR) for Patients Acutely Admitted to Hospital

    Nov 1, 2016, 00:00

  • CARDIOVASCULAR DISORDERS - Patient-Reported Outcomes Patient Preference StudiesTreatment Patterns and Medication Adherence of Acute Ischemic Stroke Patient in Korea

    Nov 1, 2016, 00:00

  • A New Coverage with Evidence Development Dedicated to Innovative Medical Biology and Pathological Anatomy and Cytology Procedures in Fran Overview of the Situation after one Year of Implementation and Focus on Innovative Genetics Procedures ...

    Nov 1, 2016, 00:00

  • The Cost of Glycaemic Target Achievement with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (MET+SU) in the UK

    Nov 1, 2016, 00:00

  • The Impact of Dynamic Transmission Modelling on the Estimated Cost-Effectiveness of Treatment for Chronic Hepatitis C in The United Kingdom

    Nov 1, 2016, 00:00

  • Patient Reported Health Utility in HR+/HER2- Advanced/Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • A Cost Effectiveness Analysis of Rosuvastatin Against Atorvastatin in Cardiovascular Diseases and Stroke- An Ambispective Study

    Nov 1, 2016, 00:00

  • Three Methods for Measuring Productivity Losses Due to Health Related Presenteeism in Economic Evaluations

    Nov 1, 2016, 00:00

  • Epidemiology of Insulin-Treated Diabetic Patients in French Regions- A Retrospective Cross-Sectional Analysis of National Health Insurance Claims Databases

    Nov 1, 2016, 00:00

  • Quality of Life for Patients Using Hemodialysis (HD) vs. Peritoneal Dialysis (PD) Modalities in Taiwan

    Nov 1, 2016, 00:00

  • Costs Evolution Of Cancer Therapies In Europe From 2004 To 2014

    Nov 1, 2016, 00:00

  • Is There an Association Between Diabetic Microvascular Complications and Serum Cholesterol? a Retrospective Analysis among Malaysian Patients with T2DM

    Nov 1, 2016, 00:00

  • Patients' Preferences For Characteristics Of Periodontal Disease And Its' Treatment- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • What Happens To Originator Medicines When (Generic) Followers Enter The Public Market

    Nov 1, 2016, 00:00

  • Review of Health Technology Assessment (HTA) Requirements for Rare Diseases Across European Countries

    Nov 1, 2016, 00:00

  • Evaluation of The Comparability of Scores From Cat and Short-Form

    Nov 1, 2016, 00:00

  • Clinical And Economic Impact Of Pharmacist Intervention At Critical Care Of Private Hospital In Riydah, Saudi Arabia

    Nov 1, 2016, 00:00

  • A Retrospective Observational Cohort Study To Investigate Treatment Outcome of Mrsa Patients Administrated with Anti-Mrsa Drugs using Large Insurance Claims Data in Japan

    Nov 1, 2016, 00:00

  • Indirect Costs Associated with Ulcerative Colitis In Poland

    Nov 1, 2016, 00:00

  • Use, Belief, and Risk Awerness to Medication Among Pregnant Women Attending Antenatal Care Unit at University of Gondar Teaching Hospital, Northwestethiopia- Crosssectional Study

    Nov 1, 2016, 00:00

  • Do More Men or Women with T2DM Achieve their Glycaemic Targets? An Exploratory Malaysian Study

    Nov 1, 2016, 00:00

  • Measuring Treatment Satisfaction and Preference in Patients with Asthma and Copd- Results of A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Prospective Utility Study of Patients with Multiple Cardiovascular Events

    Nov 1, 2016, 00:00

  • Precision Heor- Using Big Data to Develop a Personalized Modeling Framework

    Nov 1, 2016, 00:00

  • Estimating an Icer with NOAC Versus Warfarin in Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Impact of Dosing Schedule on the Success of A Vaccination Programme in an Elderly Population

    Nov 1, 2016, 00:00

  • Development of Hta In Kazakhstan

    Nov 1, 2016, 00:00

  • 7th AP - FDS Financial Disclosure Statements

    Nov 1, 2016, 00:00

  • Use of Clinical Intelligence in Monitoring Rational Drug Use Indicators in Thailand

    Nov 1, 2016, 00:00

  • Cost Utility Analysis of Monitoring Osteoporosis Fracture Risk By A Circulating Microrna Based Strategy Compared to Standard Measure and No Monitoring

    Nov 1, 2016, 00:00

  • Review of Methods for Combining Individual and Aggregate Data in a Meta-Analysis

    Nov 1, 2016, 00:00

  • Isolation and Antibiotic Susceptibility of Pathogenic Microorganisms Among UTI Patients in Tertiary Care Hospital, Abbottabad, Pakistan

    Nov 1, 2016, 00:00

  • A Methodological Issue in Effectiveness Studies of Malaria Vaccines and Chemoprevention

    Nov 1, 2016, 00:00

  • Potential Impact of The Cancer Drugs Fund Reform on Orphan Cancers

    Nov 1, 2016, 00:00

  • Beyond Risk-Based Vaccination Policies - A Life-Course Approach to Vaccination

    Nov 1, 2016, 00:00

  • Continental Comparison of Innovative Drugs Prices, The Case of Oncology Used for Treatment of Solid Tumors in Germany and The United States

    Nov 1, 2016, 00:00

  • A Systematic Review and Meta-Analysis of the Prevalence and Complications of Paraphenylene Diamine (PPD) Containing Hair Dye Poisoning in Developing Countries

    Nov 1, 2016, 00:00

  • Predictors of PD-L1 Testing in Non-Small Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Clinical Evaluation of Punarnavadi Mandoora And Tryushanadi Loha in Patients of Obesity

    Nov 1, 2016, 00:00

  • Trends In Utilization of Smoking Cessation Agents Before and After The Passage of Black Box Warning in The United States

    Nov 1, 2016, 00:00

  • Advanced Therapy Medicinal Products for Alzheimer's Disease Will Shrink the National Health Service Budget

    Nov 1, 2016, 00:00

  • Racial Differences in Cardiovascular Disease Prevalence and Mortality In the United States

    Nov 1, 2016, 00:00

  • Traditional and Complementary Medicine Use Among Women to Conceive and During Pregnancy- A Literature Review

    Nov 1, 2016, 00:00

  • The Safety And Effectiveness of Autologous Platelet Rich Plasma (Prp) Therapy For Lateral Epicondylitis- Systematic Reviews

    Nov 1, 2016, 00:00

  • Persistence with Biologic Agents for the Treatment of Rheumatoid Arthritis in Japan

    Nov 1, 2016, 00:00

  • Patients' Acceptance And Adherence Of Their Medication- Results From A European Multi-Disease Study With Online Patient Community

    Nov 1, 2016, 00:00

  • Cost Of Dengue Illness And Cost-Effectiveness Of The Cdy-Tdv Dengue Vaccine In Ecuador

    Nov 1, 2016, 00:00

  • Economic Burden of Myelodysplastic Syndromes In Croatia

    Nov 1, 2016, 00:00

  • Evaluation of Antimicrobial Stewardship Programs in Hainan, China

    Nov 1, 2016, 00:00

  • Edss State and Health Utility Measured by Eq5d in Relapsing-Remitting Multiple Sclerosis (Rrms)

    Nov 1, 2016, 00:00

  • Assessment of Patterns of Initiation of Oral Anticoagulant Therapy in Hypertensive Patients with Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Patients in Primary Care and Multimorbity

    Nov 1, 2016, 00:00

  • Study of Prescribing Pattern of Anti-Diabetic Drugs in Newly Diagnosed Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Euroqol To Assess The Quality of Life with Smartphone

    Nov 1, 2016, 00:00

  • Population Preferences for Rare Diseases in Spain

    Nov 1, 2016, 00:00

  • Utility Measures and Quality-Adjusted Life Years In Patients with Symptomatic Multivessel Coronary Artery Disease Assigned To Surgery, Angioplasty or Medical Treatment – Mass II Trial

    Nov 1, 2016, 00:00

  • Treatment Efficacy in Sequence Modelling – A Review of Published Approaches

    Nov 1, 2016, 00:00

  • Outcomes From Homeopathic Prescribing in Secondary Care Homeopathic Hospital- A Prospective Study

    Nov 1, 2016, 00:00

  • Real-World Impact Of Gender, Age And Socio-Economic Status On Type-2 Diabetes Mellitus (T2dm) Patients’ Disease Engagement And Adherence With Treatment Regimens

    Nov 1, 2016, 00:00

  • The Impact of External Price Referencing Within and Across a Country's Borders

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Levofloxacin Inhalation Solution Vs. Aztreonam Inhalation Solution In Cystic Fibrosis Patients In Belgium

    Nov 1, 2016, 00:00

  • Methods For Analyzing Patient-Reported Outcomes In Oncology Trials

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis From The Cost-Effectiveness Perspective- Is Mcda A Coherent Way To Allocate Healthcare Resources?

    Nov 1, 2016, 00:00

  • Comparison of Orphan Drug Market Access in A Sample of EU Countries, Ausralia, Canada and US

    Nov 1, 2016, 00:00

  • The Public Health Perspective Of An Investigational Herpes Zoster Vaccine In The United Kingdom (Uk)

    Nov 1, 2016, 00:00

  • When Is The Use Of A Systematic Literature Review Appropriate? A Comparison Of Systematic, Rapid, And Scoping Reviews And Their Application To The Hta Process

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Secukinumab Compared To Current Biologics Sequences For The Treatment of Moderate To Severe Plaque Psoriasis In France

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76 (current)
  • 77
  • 78
  • 79
  • 80
  • »